| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/IMT-2019-0023 |
| P698 | PubMed publication ID | 31530200 |
| P2093 | author name string | Yang Liu | |
| Peter E Fecci | |||
| Tuan Vo-Dinh | |||
| Christopher D Lascola | |||
| Paolo F Maccarini | |||
| Xiuyu Cui | |||
| Bridget M Crawford | |||
| Pakawat Chongsathidkiet | |||
| Hanna R Kemeny | |||
| Ren Odion | |||
| Cosette A Dechant | |||
| P2860 | cites work | Standardization of an orthotopic mouse brain tumor model following transplantation of CT-2A astrocytoma cells | Q40092939 |
| Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers. | Q41448543 | ||
| Ganglioside distribution in murine neural tumors | Q41600274 | ||
| Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma | Q46220499 | ||
| Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines | Q48154511 | ||
| T Cell Exhaustion Signatures Vary with Tumor Type and are Severe in Glioblastoma | Q50043938 | ||
| Stem cell marker CD133 affects clinical outcome in glioma patients. | Q53507481 | ||
| Editorial: Immunotherapy for Tumor in the Brain: Insights From-and For-Other Tumor Sites. | Q55317796 | ||
| Brain metastases | Q75253012 | ||
| Treatment and prognosis of brain metastases from breast cancer | Q81235660 | ||
| Brain metastases in breast cancer: prognostic factors and management | Q81569115 | ||
| Molecular responses to immune checkpoint blockade in glioblastoma | Q92179950 | ||
| Non-invasive sensitive brain tumor detection using dual-modality bioimaging nanoprobe | Q92271181 | ||
| Medical management of brain tumors and the sequelae of treatment | Q26992174 | ||
| The blockade of immune checkpoints in cancer immunotherapy | Q27860852 | ||
| The epidemiology of glioma in adults: a "state of the science" review | Q28387839 | ||
| TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance | Q30438480 | ||
| Gold nanostars: surfactant-free synthesis, 3D modelling, and two-photon photoluminescence imaging | Q30521396 | ||
| Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. | Q33874796 | ||
| Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors | Q33993679 | ||
| Stemness of the CT-2A Immunocompetent Mouse Brain Tumor Model: Characterization In Vitro | Q34269290 | ||
| Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis | Q34444291 | ||
| Fever and the thermal regulation of immunity: the immune system feels the heat | Q34476418 | ||
| Nanoparticles for photothermal therapies. | Q35207831 | ||
| A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy | Q35686257 | ||
| PD-1 and PD-1 ligands: from discovery to clinical application | Q36868261 | ||
| The effect of induced hyperthermia on the immune system | Q36889418 | ||
| Gold Nanostars For Surface-Enhanced Raman Scattering: Synthesis, Characterization and Optimization | Q37109471 | ||
| Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma. | Q37226831 | ||
| P433 | issue | 15 | |
| P921 | main subject | brain tumor | Q233309 |
| immunotherapy | Q1427096 | ||
| P304 | page(s) | 1293-1302 | |
| P577 | publication date | 2019-09-18 | |
| P1433 | published in | Immunotherapy | Q18713038 |
| P1476 | title | Plasmonic gold nanostar-mediated photothermal immunotherapy for brain tumor ablation and immunologic memory | |
| P478 | volume | 11 |
Search more.